Literature DB >> 9003633

Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasma.

R W Shafer1, D J Levee, M A Winters, K L Richmond, D Huang, T C Merigan.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) pol mutations are responsible for HIV-1 resistance to current antiretroviral drugs. HIV-1 RNA extraction with QIAamp HCV kit spin columns (Qiagen, Chatsworth, Calif.) followed by reverse transcription-PCR successfully recovered a 1,008-bp pol fragment from the plasma of 31 of 34 HIV-1-infected patients that was suitable for sequencing and recombinant-virus studies. The minimum HIV-1 RNA concentration required for gene recovery was 30 to 40 copies/ml, which was similar to the minimal HIV-1 RNA concentration required when phenol-chloroform or silica beads are used for RNA extraction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003633      PMCID: PMC229617          DOI: 10.1128/jcm.35.2.520-522.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction.

Authors:  M Nijhuis; C A Boucher; R Schuurman
Journal:  Biotechniques       Date:  1995-08       Impact factor: 1.993

3.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

4.  Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.

Authors:  R W Shafer; M A Winters; D L Mayers; A J Japour; D R Kuritzkes; O S Weislow; F White; A Erice; K J Sannerud; A Iversen; F Pena; D Dimitrov; L M Frenkel; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.

Authors:  S P Layne; M J Merges; M Dembo; J L Spouge; S R Conley; J P Moore; J L Raina; H Renz; H R Gelderblom; P L Nara
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

6.  Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA.

Authors:  H J Lin; L E Myers; B Yen-Lieberman; F B Hollinger; D Henrard; C J Hooper; R Kokka; S Kwok; S Rasheed; M Vahey
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

7.  Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

Authors:  P Kellam; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

8.  Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction.

Authors:  M A Winters; L B Tan; D A Katzenstein; T C Merigan
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle.

Authors:  H Zhang; Y Zhang; T Spicer; D Henrard; B J Poiesz
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  9 in total
  19 in total

1.  Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods.

Authors:  M J Espy; P N Rys; A D Wold; J R Uhl; L M Sloan; G D Jenkins; D M Ilstrup; F R Cockerill; R Patel; J E Rosenblatt; T F Smith
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Comparative study of two methods for RNA extraction prior to detection of resistance to human immunodeficiency virus type 1 with the line probe assay.

Authors:  Jose María Eiros; Cristina Labayru; Beatriz Hernández; Raúl Ortiz De Lejarazu; Antonio Rodríguez Torres
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 3.  Pre-PCR processing: strategies to generate PCR-compatible samples.

Authors:  Peter Rådström; Rickard Knutsson; Petra Wolffs; Maria Lövenklev; Charlotta Löfström
Journal:  Mol Biotechnol       Date:  2004-02       Impact factor: 2.695

4.  HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.

Authors:  Yumi Mitsuya; Mark A Winters; W Jeffrey Fessel; Soo-Yon Rhee; Sally Slome; Jason Flamm; Michael Horberg; Leo Hurley; Daniel Klein; Robert W Shafer
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

5.  Prevalence and management of invalid GeneXpert enterovirus results obtained with cerebrospinal fluid samples: a 2-year study.

Authors:  Susan E Sefers; Anna K Raymer; Jessica T Kilby; David H Persing; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

6.  Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples.

Authors:  Harald H Kessler; Alexandra M K Clarici; Evelyn Stelzl; Gerhard Mühlbauer; Elisabeth Daghofer; Brigitte I Santner; Egon Marth; Rudolf E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

7.  Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues.

Authors:  M Fischer; W Huber; A Kallivroussis; P Ott; M Opravil; R Lüthy; R Weber; R W Cone
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  HLA class II alleles: susceptibility or resistance to cystic echinococcosis in Yemeni patients.

Authors:  Abdul-Basit A Al-Ghoury; Eman M El-Hamshary; Ahmed A Azazy; Eman M Hussein; Hanan Z Rayan
Journal:  Parasitol Res       Date:  2010-04-28       Impact factor: 2.289

9.  Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  M Zazzi; L Romano; M Catucci; G Venturi; A De Milito; P E Valensin
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  The evaluation of HLA-DRB1 antigens as susceptibility markers for unilocular cystic echinococcosis in Egyptian patients.

Authors:  Magda E Azab; Sawsan A Bishara; Reda M R Ramzy; Nihad M Oteifa; Laila M El-Hoseiny; Mona A Ahmed
Journal:  Parasitol Res       Date:  2004-03-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.